Compliance with an oral asthma medication: A pilot study using an electronic monitoring device

Respiratory Medicine

Volumn 94, Issue 9, 2000, Pages 852-858

  Chung, K F ^a   Naya, I ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Asthma; Compliance; Electronic TrackCap(TM); Leukotriene receptor antagonist; Zafirlukast

Indexed keywords

ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ZAFIRLUKAST;

ADULT; ARTICLE; ASTHMA; CALCULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DRUG MONITORING; ELECTRONICS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PATIENT COMPLIANCE; PILOT STUDY; PRESCRIPTION; PRIORITY JOURNAL; RECORDING; TABLET;

EID: 0033794824     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2000.0813     Document Type: Article

References (27)

1. Compliance: A problem in medical management
2. Metered-dose inhaler adherence in a clinical trial
3. Is your asthmatic patient really complying?
4. Compliance Working Group. Compliance with nedocromil sodium and a nedocromil/salbutamol combination
5. Patient compliance with inhaled medication: Does combining beta agonists with corticosteroids improve compliance?
6. Compliance in clinical trials of two non-bronchodilator, antiasthma medications
7. Medication compliance and childhood asthma
8. Compliance with inhaled therapy and morbidity from asthma
9. Investigation of a cluster of deaths of adolescents from asthma: Evidence implicating inadequate treatment and poor patient adherence with medications
10. Death from asthma in two regions of England
11. Comparison of patients' compliance with prescribed oral and inhaled asthma medications
12. Issues in adolescent asthma: Compliance
13. Measuring adherence to asthma medication regimens
14. Oral vs inhaled asthma therapy
15. 4 receptor antagonist, in subjects with bronchial asthma
16. Zafirlukast for symptomatic mild-to-moderate asthma: A 13-week multicenter study
17. Zafirlukast improves asthma symptoms and quality of life in patients with moderate airflow obstruction
18. Long-term safety and efficacy of zafirlukast in the treatment of asthma: Interim results of an open-label extension trial
19. Objective measurements of compliance in asthma treatment
20. Compliance of patients with asthma with an experimental aerosolized medication: Implications for controlled clinical trials
21. Compliance declines between clinic visits
22. Trends in compliance with bronchodilator inhaler use between follow-up visits in a clinical trial
23. The effect of prescribed daily dose frequency on patient medication compliance
24. How often is medication taken as prescribed? A novel assessment technique
25. Compliance with prescribed drug therapy in asthma
26. Treatment preferences of adolescent patients with asthma